Studies of a neutralizing monoclonal antibody to human immunodeficiency virus type 1 reverse transcriptase: Antagonistic and synergistic effects in reactions performed in the presence of nucleoside and nonnucleoside inhibitors, respectively

Journal of Virology

Volumn 70, Issue 4, 1996, Pages 2620-2626

  Gu, Zhengxian ^a   Li, Xuguang ^a   Quan, Yudong ^a   Parniak, Michael A ^a   Wainberg, Mark A ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2',3' DIDEOXYCYTIDINE 5' TRIPHOSPHATE; 3' AZIDO 2',3' DIDEOXYURIDINE; DELAVIRDINE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 1E8; MONOCLONAL ANTIBODY RT 4; NEUTRALIZING ANTIBODY; NEVIRAPINE; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; DRUG ANTAGONISM; DRUG POTENTIATION; ENZYME INHIBITION; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; REACTION ANALYSIS; VIRUS NEUTRALIZATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIVIRAL AGENTS; DELAVIRDINE; DEOXYCYTOSINE NUCLEOTIDES; DNA; HIV ANTIBODIES; HIV-1 REVERSE TRANSCRIPTASE; HUMANS; INDOLES; MICE; NEUTRALIZATION TESTS; NEVIRAPINE; PEPTIDE CHAIN ELONGATION, TRANSLATIONAL; PIPERAZINES; PYRIDINES; REVERSE TRANSCRIPTASE INHIBITORS; RNA-DIRECTED DNA POLYMERASE; THYMINE NUCLEOTIDES; ZIDOVUDINE;

EID: 0029970470     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.4.2620-2626.1996     Document Type: Article

References (32)

1. Abbotts, J., K. Bebenek, T. A. Kunkel, and S. H. Wilson. 1993 Mechanism of HIV-1 reverse transcriptase: termination of processive synthesis on a natural DNA template is influenced by the sequence of the template-primer system. J. Biol. Chem. 268:10312-10323.
2. Lys-3 as primers in an endogenous human immunodeficiency virus-1 in vitro reverse transcription/ template-switching reaction. J. Biol. Chem. 269:14672-14680.
3. Arts, E. J., J.-P. Marois, Z. Gu, S. F. J. LeGrice, and M. A. Wainberg. 1996. Effects of 3′-deoxynucleoside 5′-triphosphate concentrations on chain termination by nucleoside analogs during human immunodeficiency virus type 1 reverse transcription of minus-strand strong-stop DNA. J. Virol 70:712-720
4. Boyer, P. L., A. I. Ferris, and S. H. Hughes. 1992. Cassette mutagenesis of the reverse transcriptase of human immunodeficiency virus type 1. J. Virol. 66:1031-1039.
5. Boyer, P. L., C. Tantillo, A. Jacobo-Molina, R. G. Nanni, J. Ding, E. Arnold, and S. H. Hughes. 1994. Sensitivity of wild-type human immunodeficiency virus type 1 reverse transcriptase to dideoxynucleotides depends on template length: the sensitivity of drug-resistant mutants does not Proc Natl. Acad Sci. USA 91:4882-4886.
6. Cheng, N., B. M. Merrill, G. R. Painter, L. W. Frick, and P. A. Furman. 1993. Identification of the nucleotide binding site of HIV-1 reverse transcriptase using dTTP as a photoaffinity label. Biochemistry 32:7630-7634.
7. Cohen, K. A., J. Hopkins, R. H. Ingraham, C. Pargellis, J. C. Wu, D. E. H. Palladino, P. Kinkada, T. C. Warren, S. Rogers, J. Adams, P. R. Farina, and P. M. Grob. 1991. Characterization of the binding site for Nevirapine (BI-RG-587). a nontiucleoside inhibitor of human immunodeficiency virus type 1 reverse transcriptase. J Biol. Chem. 266:14670-14674.
8. Fitzgibbon, J. E., R. M. Howell, C. A. Haberzettl, S. J. Sperber, D. J. Gocke, and D. T. Dubin. 1992. Human immunodeficiency virus type 1 pol gene mutations which cause decreased susceptibility to 2′,3′-dideoxycytidine. Antimicrob. Agents Cheraother. 36:153-157
9. Furman, P. A., J. A. Fyfe, M. H. St. Clair, K. Weinhold, J. L. Rideout, G. A. Freeman, S. Nusinoff-Lehrman, D. P. Bolognesi, S. Broder, H. Mitsuya, and D. W. Barry. 1986. Phosphorylation of 3′-azido-3′-deoxythymidine and selective interaction of the 5′-triphosphate with human immunodeficiency virus reverse transcriptase. Proc. Natl. Acad. Sci. USA 83:8333-8337.
10. Goldman, M. E., J. H. Nunberg, J. A. O'Brien, J. C. Quintero, W. A. Schleif, K. F. Freund, S. L. Gaul, W. S. Saari, J. S. Wai, J. M. Hoffman, P. S. Andersen, D. J. Hupe, E. A. Emini, and A. M. Stern. 1991. Pyridinon derivatives: specific human immunodeficiency virus type 1 reverse transcriptase inhibitors with antiviral activity Proc Natl Acad. Sci. USA 88:6863-6867.
11. Gu, Z., K. J. Arts, M. A. Parniak, and M. A. Wainberg. 1995. Mutated K65R recombinant HIV-1 reverse transcriptase shows diminished chain termination in the presence of 2′,3′-dideoxycytidine-5′-triphosphate and other drugs Proc. Natl Acad. Sci. USA 92:2760-2764.
12. Gu, Z., R. S. Fletcher, E. J. Arts, M. A. Wainberg, and M. A. Parniak. 1994. The K65R mutant reverse transcriptase of HIV-1 cross-resistance to 2′,3′-dideoxyinosine shows reduced sensitivity to specific dideoxynucleoside trihosphate inhibitors in vitro. J. Biol. Chem. 269:28118-28122.
13. Gu, Z., Q. Gao, H. Fang, H. Salomon, M. A. Parniak, E. Goldberg, J. Cameron, and M. A. Wainberg. 1994. Identification of a mutation at codon 65 in the IKKK motif of reverse transcriptase that encodes human immunodeficiency virus resistance to 2′3′-dideoxycytidine and 2′,3′-dideoxy-3′-thiacytidine Antimicrob. Agents Chemother. 38:275-281.
14. Gu, Z., Y. Quan, Z. Li, E. J. Arts, and M. A. Wainberg. 1995. Effects of non-nucleoside inhibitors of human immunodeficiency virus type 1 in cell-free recombinant reverse transcriptase assays J. Biol Chem 270:31046-31051.
15. Huber, H. E., J. M. McCoy, J. S. Seehra, and C. C. Richardson. 1989. Human immunodeficiency virus type 1 reverse transcriptase template binding, processivity. strand displacement synthesis, and template switching. J. Biol. Chem. 264:4669-4678.
16. Jacobo-Molina, A., J. Ding, R. G. Nanni, A. D. Clark, Jr., X. Lu, C. Tantillo, R. L. Williams, G. Kamer, A. L. Ferris, P. Clark, A. Hizi, S. H. Hughes, and E. Arnold. 1993. Crystal structure of human immunodeficiency virus type 1 reverse transcriptase completed with double-stranded DNA at 3 0 A resolution shows bent DNA. Proc. Natl. Acad. Sci. USA 90:6320-6324.
17. Kedar, P. S., J. Abbotts, T. Kovacs, K. Lesiak, P. Torrence, and S. H. Wilson. 1990. Mechanism of HIV reverse transcriptase. enzyme-primer interaction as revealed through studies of a dNTP analog, 3′-azido-dTTP Biochemistry 29:3603-3611.
18. Klarmann, G. J., C. A. Schauber, and B. D. Preston. 1993. Template-directed pausing of DNA synthesis by HIV-1 reverse transcriptase during polymerization of HIV-1 sequences in vitro. J. Biol. Chem. 268:9793-9802.
19. Kohlstaedt, L. A., J. Wang, J. M. Freedman, P. A. Rice, and T. A. Steitz. 1992 Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase completed with an inhibitor. Science 256:1783-1790.
20. Larder, B. A., and S. D. Kemp. 1989. Multiple mutations in HIV-1 reverse transcriptasd confer high-level resistance to zidovudine (AZT). Science 246:1155-1158
21. Li, X., E. Amandoron, M. A. Wainberg, and M. A. Parniak. 1993 Generation and characterization of murine monoclonal antibodies reactive against N-terminal and oiher regions of HIV-1 reverse transcriptase J. Med. Virol 39:251-759.
22. Mauiejewski, J. P., F. F. Weichold, N. S. Young, A. Cara, D. Zella, M. S. Reitz, Jr., and R. C. Gallo. 1995. Intracellular expression of antibody fragments directed against HIV reverse transcriptase prevents HIV infection in vitro. Nat. Med. 1:667-673.
23. Majumdar, C., J. Abbotts, S. Broder, and S. H. Wilson. 1988 Studies on the mechanism of human immunodeficiency virus reverse transcriptase: steady-state kinetics, processivity, and polynucleotide inhibition. J. Biol. Chem. 263:15657-15665.
24. Martin, J. L., J. E. Wilson, R. L. Haynes, and P. A. Furman. 1993. Mechanism of resistance of human immunodeficiency virus type 1 to 2′,3′-dideoxyinosme Proc Natl. Acad Sci USA 90:6135-6139.
25. Mitsuya, H., R. F. Jarrett, M. Matsukura, F. D. M. Veronese, A. L. DeVico, M. G. Sarngadharn, D. G. Johns, M. S. Reitz, and S. Broder. 1987. Long-term inhibition of human T-iymphotropic virus III lymphadenopathy-associated virus (human immunodeficiency virus) DNA synthesis and RNA expression in T cells protected by 2′,3′-dideoxynucleotides in vitro Proc. Natl Acad Sci. USA 84:2033-2037
26. Skalka, A. M., and S. P. Goff (ed.). 1993. Reverse transcriptase Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y
27. Spence, R. A., W. M. Kati, K. S. Anderson, and K. A. Johnson. 1995. Mechanism of inhibition of HIV-1 reverse transcriptase by nonnucleoside inhibitors. Science 267:988-992.
28. St. Clair, M. H., J. L. Martin, G. Tudor-Williams, M. C. Bach, C. L. Vavro, D. M. King, P. Kellam, S. D. Kemp, and B. A. Larder. 1991. Resistance to ddI and sensitivity to AZT induced by a mutation in HIV-1 reverse transeriptase. Science 253:1557-1559.
29. St. Clair, M. H., C. A. Richards, T. Spector, K. J. Weinhold, W. H. Miller, A. J. Langlois, and P. A. Furman. 1987. 3′-Azido-3′-deoxythymidine triphosphate as an inhibitor and substrate of purified human immunodeficiency virus reverse transcriptase. Antimicrob. Agents Chemother 31:1972-1977
30. Wu, J., E. Amandoron, X. Li, M. A. Wainberg, and M. A. Parniak. 1993. Monoclonal antibody-mediated inhibition of HIV-1 reverse transcriptase polymerase activity, J. Biol. Chem. 268:9980-9985.
31. Wu, J. C., T. C. Warren, J. Adams, J. Proudfoot, J. Skiles, P. Raghavan, C. Perry, I. Potocki, P. R. Farina, and P. M. Grob. 1991. A novel dipyridodiazepinone inhibitor of HIV-1 reverse transcriptase acts through a nonsubstrate binding site Biochemistry 30:2022-2026.
32. Zhang, D., A. M. Caliendo, J. J. Eron, K. M. DeVore, J. C. Kaplan, M. S. Hirsch, and R. T. D'Aquila. 1994. Resistance to 2′,3′-dideoxycytidine conferred by a mutation in codon 65 of the human immunodeficiency virus type 1 reverse transcriptase. Antimicrob Agents Chemother 38:282-287